More on IPSEY
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $40.93 |
|
|||
| Open | $43.00 | ||||
| 52 Wk High | $17.79 | ||||
| 52 Wk Low | $13.01 | ||||
| Day High | $43.00 | ||||
| Day Low | $43.00 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 337 | ||||
- Ipsen names Mariette Finet to its board of directors
- Ipsen appoints Mariette Finet to its Board of Directors
- Ipsen adds Catherine Bradley to its board as independent director
- Ipsen nominates Catherine Bradley to its Board of Directors as independent Director
- Ipsen completes acquisition of Memo Therapeutics AG
- Ipsen acquires Memo Therapeutics, adding kidney transplant drug
- Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline
- Ipsen SA (IPN:FP) (IPSEY) PT Raised to EUR235 at H.C. Wainwright
- National Survey From Ipsen Shows Young People Are Not Prepared for the Shift From Pediatric to Adult Healthcare
- Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction
Entities mentioned with IPSEY
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- Dividend | View Related Stories »
- Stock Buyback | View Related Stories »
- S1 | View Related Stories »
- Deutsche Bank | View Related Stories »
- Show More...
